JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258754

Human USP34 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

USP34 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon3 and 8 bp deletion in exon3.

View Alternative Names

Deubiquitinating enzyme 34, FLJ43910, KIAA0570, KIAA0729, MGC104459, UBP34_HUMAN, Ubiquitin carboxyl-terminal hydrolase 34, Ubiquitin specific protease 34, Ubiquitin thioesterase 34, Ubiquitin thiolesterase 34, Ubiquitin-specific-processing protease 34

2 Images
Sanger Sequencing - Human USP34 knockout HeLa cell lysate (AB258754)
  • Sanger seq

Unknown

Sanger Sequencing - Human USP34 knockout HeLa cell lysate (AB258754)

Allele-2 : 2 bp deletion in exon3

Sanger Sequencing - Human USP34 knockout HeLa cell lysate (AB258754)
  • Sanger seq

Unknown

Sanger Sequencing - Human USP34 knockout HeLa cell lysate (AB258754)

Allele-1 : 8 bp deletion in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon3 and 8 bp deletion in exon3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258754-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human USP34 knockout HeLa cell lysate", "number":"AB258754-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258754-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
USP34
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

USP34 also known as ubiquitin specific peptidase 34 is a deubiquitinating enzyme that plays an essential role in the removal of ubiquitin moieties from target proteins. It weighs approximately 440 kDa. It is present in various tissues with notable expression in the brain heart and skeletal muscles. As a hydrolase USP34 removes ubiquitin chains affecting the stability and activity of proteins involved in several cellular processes.
Biological function summary

Ubiquitin specific peptidase 34 regulates protein homeostasis by controlling the degradation of ubiquitinated proteins. Its activity influences pathways such as Wnt signaling where it interacts with components of this signal transduction pathway to modulate cellular responses. Although USP34 can act independently it may also partner with other proteins in cellular complexes to assist in its deubiquitinating roles and to maintain appropriate protein levels.

Pathways

USP34 significantly impacts Wnt signaling and the TGF-beta pathway. In the Wnt signaling pathway it targets the degradation of beta-catenin which is pivotal for transcriptional activation in various cells. In the TGF-beta pathway USP34's regulation is important for promoting correct cellular responses. It interacts with proteins like SMAD and AXIN helping to maintain the pathways' integrity and balance cellular proliferation.

Ubiquitin specific peptidase 34 has connections to cancer and neurodegenerative diseases. Dysregulation of its deubiquitinating activity can result in abnormal protein stabilization which is a contributing factor in tumor growth and progression. In neurodegenerative diseases impaired USP34 function affects neuronal proteins linking it to disorders such as Alzheimer's disease. Proteins like beta-amyloid and tau often involved in these conditions have indirect associations with the activity of USP34 highlighting its potential role in disease processes.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com